Right Ventricular Function at Cardiac MRI Predicts Cardiovascular Events in Patients with an Implantable Cardioverter-Defibrillator.
Laura Jimenez-JuanNissan Ben-DovCaio V Goncalves FrazaoNigel S TanSheldon M SinghPaul DorianPaul AngaranAnastasia OikonomouLan-Chau T KhaIdan RoifmanBinita ChackoKim A ConnellyAnish KirpalaniDjeven Parameshvara DevaAndrew T YanPublished in: Radiology (2021)
Background Right ventricular ejection fraction (RVEF) is an independent predictor of death and adverse cardiovascular outcomes in patients with various cardiac conditions. Purpose To investigate whether RVEF, measured with cardiac MRI, is a predictor of appropriate shock or death in implantable cardioverter-defibrillator (ICD) recipients for primary and secondary prevention of sudden cardiac death. Materials and Methods This retrospective, multicenter, observational study included patients who underwent cardiac MRI before ICD implantation between January 2007 and May 2017. Right ventricular end-diastolic and end-systolic volumes and RVEF were measured with cardiac MRI. The primary end point was a composite of all-cause mortality or appropriate ICD shock. The secondary end point was all-cause mortality. The association between RVEF and primary and secondary outcomes was evaluated by using multivariable Cox regression analysis. Potential interactions were tested between primary prevention, ischemic cause, left ventricular ejection fraction (LVEF), and RVEF. Results Among 411 patients (mean age ± standard deviation, 60 years; 315 men) during a median follow-up of 63 months, 143 (35%) patients experienced an appropriate ICD shock or died. In univariable analysis, lower RVEF was associated with greater risks for appropriate ICD shock or death and for death alone (log-rank trend test, P = .003 and .005 respectively). In multivariable Cox regression analysis adjusting for age at ICD implantation, LVEF, ICD indication (primary vs secondary), ischemic heart disease, and late gadolinium enhancement, RVEF was an independent predictor of the primary outcome (hazard ratio [HR], 1.21 per 10% lower RVEF; 95% CI: 1.04, 1.41; P = .01) and all-cause mortality (HR, 1.25 per 10% lower RVEF; 95% CI: 1.01, 1.55; P = .04). No evidence of significant interactions was found between RVEF and primary or secondary prevention (P = .49), ischemic heart disease (P = .78), and LVEF (P = .29). Conclusion Right ventricular ejection fraction measured with cardiac MRI was a predictor of appropriate implantable cardioverter-defibrillator shock or death. © RSNA, 2021 See also the editorial by Nazarian and Zghaib in this issue. An earlier incorrect version of this article appeared online. This article was corrected on August 24, 2021.
Keyphrases
- ejection fraction
- left ventricular
- aortic stenosis
- contrast enhanced
- magnetic resonance imaging
- cardiovascular events
- heart failure
- acute myocardial infarction
- diffusion weighted imaging
- hypertrophic cardiomyopathy
- blood pressure
- coronary artery disease
- left atrial
- type diabetes
- magnetic resonance
- cardiovascular disease
- transcatheter aortic valve replacement
- computed tomography
- social media
- newly diagnosed
- emergency department
- chronic kidney disease
- adipose tissue
- percutaneous coronary intervention
- insulin resistance
- brain injury
- blood brain barrier
- cross sectional
- aortic valve